About the journal
OncoTargets and Therapy is an open-access journal published by Dove Medical Press in New Zealand. It is listed in PUBMED according to the sources read. Declared publication charge: 2,836 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Dove Medical Press
- ISSN
- 1178-6930
- Country
- New Zealand
- Access
- Open access
- Declared publication charge
- 2,836 USD
- Official website
- http://www.dovepress.com/oncotargets-and-therapy-journal
Index listings
- PUBMED · 2008-07-01
- Indexing
- PUBMED
- APC
- 2,836 USD
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
6813
Last recorded publication year
2026
h-index
112
i10-index
4538
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSS
- Open references deposited at Crossref
- 63%
- ORCID iDs in current deposits
- 60%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101514322
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- Circular RNAs in diseases
- Circular RNAs in diseases
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
Show all subjects (50)
- Ferroptosis and cancer prognosis
- Ferroptosis and cancer prognosis
- RNA modifications and cancer
- RNA modifications and cancer
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Cancer Mechanisms and Therapy
- Cancer Mechanisms and Therapy
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Inflammatory Biomarkers in Disease Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- Wnt/β-catenin signaling in development and cancer
- Cancer Genomics and Diagnostics
- Wnt/β-catenin signaling in development and cancer
- Cancer-related gene regulation
- Cancer Genomics and Diagnostics
- Cancer-related gene regulation
- Cytokine Signaling Pathways and Interactions
- Cytokine Signaling Pathways and Interactions
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ